Data gathered: November 22
AI Stock Analysis - Insulet (PODD)
Analysis generated November 8, 2024. Powered by Chat GPT.
Insulet Corporation (NASDAQ: PODD) is a medical device company that specializes in the development, manufacturing, and sale of its Omnipod Insulin Management System. The Omnipod System is a unique method of delivering insulin, enhancing the convenience and flexibility for patients with diabetes. By focusing on user-friendly, innovative, and effective diabetes management solutions, Insulet continues to make significant strides in the healthcare technology sector.
Stock Alerts - Insulet (PODD)
 |
Insulet | November 8 Price is up by 10.8% in the last 24h. |
|
Insulet | November 7 AI Score is up by 20.9% in the last couple of days. |
|
Insulet | November 5 Job postings are up by 71.6% in the last couple of days. |
|
Insulet | October 5 Job postings are up by 78.3% in the last couple of days. |
Alternative Data for Insulet
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 236 | Sign up | Sign up | Sign up |
| Sentiment | 89 | Sign up | Sign up | Sign up |
| Webpage traffic | 62,000 | Sign up | Sign up | Sign up |
| Employee Rating | 82 | Sign up | Sign up | Sign up |
| Google Trends | 74 | Sign up | Sign up | Sign up |
| Patents | 272 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 20,680 | Sign up | Sign up | Sign up |
| Facebook Followers | 81,634 | Sign up | Sign up | Sign up |
| Instagram Followers | 55,234 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,774 | Sign up | Sign up | Sign up |
| Twitter Followers | 7,995 | Sign up | Sign up | Sign up |
| Twitter Mentions | 9 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 83 | Sign up | Sign up | Sign up |
| Linkedin Employees | 3,456 | Sign up | Sign up | Sign up |
About Insulet
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
| Price | $262.93 |
| Target Price | Sign up |
| Volume | 453,490 |
| Market Cap | $18.7B |
| Year Range | $161.02 - $275.7 |
| Dividend Yield | 0% |
| PE Ratio | 45.41 |
| Analyst Rating | 88% buy |
| Industry | Medical Devices |
In the news
 |
B. Metzler seel. Sohn & Co. Holding AG Invests $2.22 Million in Insulet Co. (NASDAQ:PODD)November 22 - ETF Daily News |
|
Banque Cantonale Vaudoise Sells 5,218 Shares of Insulet Co. (NASDAQ:PODD)November 22 - ETF Daily News |
|
Natixis Advisors LLC Grows Holdings in Insulet Co. (NASDAQ:PODD)November 22 - ETF Daily News |
 |
Insulet adds Abbott’s FreeStyle Libre 2 Plus to Omnipod 5’s compatibility rosterNovember 20 - Yahoo |
 |
Insulet: Superb Business Growth, Starting Valuations Outsized RiskNovember 20 - SeekingAlpha |
 |
Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The SidelinesNovember 20 - SeekingAlpha |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 544M | 167M | 377M | 78M | 91M | 0.900 |
| Q2 '24 | 489M | 158M | 331M | 189M | 57M | 0.550 |
| Q1 '24 | 442M | 135M | 307M | 52M | 68M | 0.730 |
| Q4 '23 | 510M | 149M | 361M | 103M | 117M | 1.400 |
| Q3 '23 | 433M | 139M | 293M | 52M | 67M | 0.710 |
Insider Transactions View All
| Hopfield Jessica filed to sell 26,917 shares at $225.3. September 12 '24 |
| Scannell Timothy J filed to sell 30,586 shares at $225.8. September 11 '24 |
| Budden Lauren filed to sell 6,609 shares at $221.4. September 10 '24 |
| Field Mark N filed to sell 9,761 shares at $220.9. September 10 '24 |
| Singh Prem filed to sell 3,656 shares at $202.3. September 3 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Christine Smith Democrat |
Apr 19, 24 | Sell | $50K - $100K |
| Markwayne Mullin Republican |
Jan 26, 24 | Sell | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Sell | $1K - $15K |
Read more about Insulet (PODD) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Insulet?
The Market Cap of Insulet is $18.7B.
What is Insulet's PE Ratio?
As of today, Insulet's PE (Price to Earnings) ratio is 45.41.
What is the current stock price of Insulet?
Currently, the price of one share of Insulet stock is $262.93.
How can I analyze the PODD stock price chart for investment decisions?
The PODD stock price chart above provides a comprehensive visual representation of Insulet's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Insulet shares. Our platform offers an up-to-date PODD stock price chart, along with technical data analysis and alternative data insights.
Does PODD offer dividends to its shareholders?
As of our latest update, Insulet (PODD) does not offer dividends to its shareholders. Investors interested in Insulet should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Insulet?
Some of the similar stocks of Insulet are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.